Literature DB >> 2398544

Integration of human immunodeficiency virus types 1 and 2 DNA in vitro by cytoplasmic extracts of Moloney murine leukemia virus-infected mouse NIH 3T3 cells.

C Vink1, D C van Gent, R H Plasterk.   

Abstract

An essential step in the life cycle of the human immunodeficiency virus (HIV) is integration of a DNA copy of the viral RNA into the genome of the infected cell. We show here that this step can be faithfully accomplished in vitro by the enzymatic machinery of another retrovirus, Moloney murine leukemia virus (MoMLV). Mini-HIV substrates, which are linearized plasmids with long terminal repeat sequences at their ends, were incubated with cytoplasmic extracts of MoMLV-infected NIH 3T3 cells and target DNA. The MoMLV integration apparatus carried out integration of the mini-HIV substrates correctly; the terminal nucleotides of the viral substrate were removed, and a 4-base-pair duplication of the target DNA flanked the inserted viral DNA (C. Shoemaker, S. P. Goff, E. Gilboa, M. Paskind, S. W. Mitra, and D. Baltimore, Proc. Natl. Acad. Sci. USA 77:3932-3936, 1980). Our experiments show that the substrate sequence requirements for integration in vitro were limited to a few nucleotides, as the similarity between HIV and MoMLV long terminal repeat ends is minimal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398544      PMCID: PMC248022     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes.

Authors:  M S Johnson; M A McClure; D F Feng; J Gray; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

4.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

5.  Nucleotide sequence of bacteriophage lambda DNA.

Authors:  F Sanger; A R Coulson; G F Hong; D F Hill; G B Petersen
Journal:  J Mol Biol       Date:  1982-12-25       Impact factor: 5.469

6.  Purification of genomic sequences from bacteriophage libraries by recombination and selection in vivo.

Authors:  B Seed
Journal:  Nucleic Acids Res       Date:  1983-04-25       Impact factor: 16.971

7.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site.

Authors:  J Colicelli; S P Goff
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

View more
  14 in total

1.  Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase.

Authors:  M L Fitzgerald; A C Vora; W G Zeh; D P Grandgenett
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors.

Authors:  Deborah J Lee; W Edward Robinson
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein.

Authors:  C Vink; E Yeheskiely; G A van der Marel; J H van Boom; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

5.  DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein.

Authors:  F M van den Ent; C Vink; R H Plasterk
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Analysis of the junctions between human immunodeficiency virus type 1 proviral DNA and human DNA.

Authors:  C Vink; M Groenink; Y Elgersma; R A Fouchier; M Tersmette; R H Plasterk
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Authors:  C Vink; K H van der Linden; R H Plasterk
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase.

Authors:  G A Donzella; C B Jonsson; M J Roth
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration.

Authors:  C B Jonsson; M J Roth
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Comparison of DNA binding and integration half-site selection by avian myeloblastosis virus integrase.

Authors:  D P Grandgenett; R B Inman; A C Vora; M L Fitzgerald
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.